Form 4 for FRPT Freshpet, Inc.
Accepted 2026-05-19 17:52:40 ET · period of report 2026-05-15 · accession 0000929638-26-001928 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $10.23 | +124.7K | 227.8K | +121% | +$1.28M |
| DMT | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | S - Sale+OE | $49.11 | -85.4K | 185.1K | -32% | -$4.19M |
| DMTI | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $10.23 | +43.3K | 45.1K | +2,312% | +$442.6K |
| DMTI | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | S - Sale+OE | $49.56 | -8,979 | 43.5K | -17% | -$445.0K |
| DMT | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $0.00 | -124.7K | 493.0K | -20% | $0 |
| DMTI | 2026-05-19 17:52 | 2026-05-15+ | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $0.00 | -43.3K | 63.1K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | M | A | 62,369 | $10.23 | 208,139 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 6,104 | $48.44 | 202,035 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.81 to $48.74. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 3 | Common | Common Stock | 2026-05-15 | S | D | 36,289 | $49.46 | 165,746 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.81 to $49.80. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 4 | Common | Common Stock | 2026-05-15 | S | D | 300 | $49.85 | 165,446 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $49.89. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 5 | Common | Common Stock | 2026-05-18 | M | A | 62,369 | $10.23 | 227,815 | D | — | — | |
| 6 | Common | Common Stock | 2026-05-18 | S | D | 32,344 | $48.46 | 195,471 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F5) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 7 | Common | Common Stock | 2026-05-18 | S | D | 1,526 | $49.09 | 193,945 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F6) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 8 | Common | Common Stock | 2026-05-18 | S | D | 7,513 | $50.36 | 186,432 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F7) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 9 | Common | Common Stock | 2026-05-18 | S | D | 1,309 | $51.32 | 185,123 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F8) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68. (F9) The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| 10 | Common | Common Stock | 2026-05-15 | M | A | 4,620 | $10.23 | 15,545 | I By Spouse | — | — | |
| 11 | Common | Common Stock | 2026-05-15 | S | D | 959 | $49.09 | 14,586 | I By Spouse | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 12 | Common | Common Stock | 2026-05-18 | M | A | 4,620 | $10.23 | 19,206 | I By Spouse | — | — | |
| 13 | Common | Common Stock | 2026-05-18 | S | D | 959 | $50.04 | 18,247 | I By Spouse | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 14 | Common | Common Stock | 2026-05-15 | M | A | 9,030 | $10.23 | 41,044 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | |
| 15 | Common | Common Stock | 2026-05-15 | S | D | 1,874 | $49.09 | 39,170 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 16 | Common | Common Stock | 2026-05-18 | M | A | 9,030 | $10.23 | 48,200 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | |
| 17 | Common | Common Stock | 2026-05-18 | S | D | 1,874 | $50.04 | 46,326 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 18 | Common | Common Stock | 2026-05-15 | M | A | 7,981 | $10.23 | 38,809 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | |
| 19 | Common | Common Stock | 2026-05-15 | S | D | 1,657 | $49.09 | 37,152 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 20 | Common | Common Stock | 2026-05-18 | M | A | 7,981 | $10.23 | 45,133 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | |
| 21 | Common | Common Stock | 2026-05-18 | S | D | 1,656 | $50.04 | 43,477 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 22 | Derivative | Options to purchase common stock | 2026-05-15 | M | D | 62,369 | $0.00 | 555,393 | D | $10.23 · — to 2026-09-06 | 62,369 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 23 | Derivative | Options to purchase common stock | 2026-05-18 | M | D | 62,369 | $0.00 | 493,024 | D | $10.23 · — to 2026-09-06 | 62,369 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 24 | Derivative | Options to purchase common stock | 2026-05-15 | M | D | 4,620 | $0.00 | 41,140 | I By Spouse | $10.23 · — to 2026-09-06 | 4,620 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 25 | Derivative | Options to purchase common stock | 2026-05-18 | M | D | 4,620 | $0.00 | 36,520 | I By Spouse | $10.23 · — to 2026-09-06 | 4,620 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 26 | Derivative | Options to purchase common stock | 2026-05-15 | M | D | 9,030 | $0.00 | 80,410 | I By Irrevocable Spousal Trust for Linda W. Cyr | $10.23 · — to 2026-09-06 | 9,030 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 27 | Derivative | Options to purchase common stock | 2026-05-18 | M | D | 9,030 | $0.00 | 71,380 | I By Irrevocable Spousal Trust for Linda W. Cyr | $10.23 · — to 2026-09-06 | 9,030 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 28 | Derivative | Options to purchase common stock | 2026-05-15 | M | D | 7,981 | $0.00 | 71,057 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | $10.23 · — to 2026-09-06 | 7,981 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 29 | Derivative | Options to purchase common stock | 2026-05-18 | M | D | 7,981 | $0.00 | 63,076 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | $10.23 · — to 2026-09-06 | 7,981 Common Stock | (F10) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |